Compania de Minas Buenaventura SAA ADR (BVN)vsVersamet Royalties Corporation Common Stock (VMET)
BVN
Compania de Minas Buenaventura SAA ADR
$35.36
+4.21%
BASIC MATERIALS · Cap: $8.62B
VMET
Versamet Royalties Corporation Common Stock
$10.83
-4.41%
BASIC MATERIALS · Cap: $1.32B
Smart Verdict
WallStSmart Research — data-driven comparison
Compania de Minas Buenaventura SAA ADR generates 5793% more annual revenue ($2.05B vs $34.76M). VMET leads profitability with a 58.5% profit margin vs 47.7%. BVN trades at a lower P/E of 10.3x. BVN earns a higher WallStSmart Score of 82/100 (A-).
BVN
Exceptional Buy82
out of 100
Grade: A-
VMET
Hold45
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+21.6%
Fair Value
$51.60
Current Price
$35.36
$16.24 discount
Intrinsic value data unavailable for VMET.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Keeps 48 of every $100 in revenue as profit
Strong operational efficiency at 52.5%
Revenue surging 103.0% year-over-year
Earnings expanding 139.4% YoY
Safe zone — low bankruptcy risk
Keeps 59 of every $100 in revenue as profit
Strong operational efficiency at 135.6%
Revenue surging 465.2% year-over-year
Areas to Watch
No major concerns identified
0.0% earnings growth
Smaller company, higher risk/reward
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : BVN
The strongest argument for BVN centers on P/E Ratio, Profit Margin, Operating Margin. Profitability is solid with margins at 47.7% and operating margin at 52.5%. Revenue growth of 103.0% demonstrates continued momentum.
Bull Case : VMET
The strongest argument for VMET centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 58.5% and operating margin at 135.6%. Revenue growth of 465.2% demonstrates continued momentum.
Bear Case : BVN
No major red flags identified for BVN, but monitor valuation.
Bear Case : VMET
The primary concerns for VMET are EPS Growth, Market Cap, P/E Ratio. A P/E of 58.0x leaves little room for execution misses.
Key Dynamics to Monitor
VMET is growing revenue faster at 465.2% — sustainability is the question.
BVN generates stronger free cash flow (232M), providing more financial flexibility.
Monitor OTHER PRECIOUS METALS & MINING industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BVN scores higher overall (82/100 vs 45/100), backed by strong 47.7% margins and 103.0% revenue growth. Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Compania de Minas Buenaventura SAA ADR
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Compaa de Minas Buenaventura SAA, a precious metals company, is dedicated to the exploration, extraction, concentration, smelting and commercialization of minerals and polymetallic metals in Peru, the United States, Europe and Asia. The company is headquartered in Lima, Peru.
Visit Website →Versamet Royalties Corporation Common Stock
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Viamet Pharmaceuticals Corp (VMET) is a biopharmaceutical company focused on developing novel therapeutics for serious and life-threatening diseases, particularly through its innovative drug development platform that leverages its proprietary metalloenzyme-based technology. The company aims to address unmet medical needs in areas such as fungal infections and oncology, positioning itself at the forefront of therapeutic innovation. Viamet's strategic partnerships and strong intellectual property portfolio underscore its commitment to advancing its pipeline while maximizing shareholder value. As it progresses through clinical development phases, VMET stands to play a significant role in transforming treatment paradigms within its targeted therapeutic areas.
Compare with Other OTHER PRECIOUS METALS & MINING Stocks
Want to dig deeper into these stocks?